Synergistic effects of the sesquiterpene lactone, EPD, with cisplatin and paclitaxel in ovarian cancer cells

被引:0
作者
Caroline van Haaften
Arnoud Boot
Willem E Corver
Jaap DH van Eendenburg
Baptist JMZ Trimbos
Tom van Wezel
机构
[1] Leiden University Medical Center,Department of Gynecology
[2] Leiden University Medical Center,Department of Pathology
来源
Journal of Experimental & Clinical Cancer Research | / 34卷
关键词
Ovarian cancer; EPD; Cisplatin; Paclitaxel; Synergism;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 129 条
[1]  
Clarke MF(2006)Cancer stem cells-Perspectives on current status and future directions: AACR Workshop on cancer stem cells Cancer Res 66 9339-44
[2]  
Dick JE(2012)Ovarian cancer stem cells: elusive targets for chemotherapy. Review article Med Oncol 29 3400-8
[3]  
Dirks PB(2011)Rethinking Ovarian cancer: Recommendations for Improving Outcomes Nat Rev Cancer 11 719-25
[4]  
Eaves CJ(1994)Synergistic interaction between cisplatin and paclitaxel in human ovarian carcinoma cells Br J Cancer 69 299-306
[5]  
Jamieson CHM(1995)Schedule-dependent Antagonism of Paclitaxel and Cisplatin in Human Gastric and Ovarian Carcinoma Cell lines Eur J Cancer 1 92-7
[6]  
Jones DL(2007)Biochemical mechanisms of cisplatin cytotoxicity Anticancer Agents Med Chem 7 3-18
[7]  
Guddati AK(2011)Potent cytotoxic effects of J Exp Clin Cancer Res 1 29-21
[8]  
Vaughan S(1976) on ovarian cancers Chem Pharm Bull 24 1419-7
[9]  
Coward JI(2011)Chemische untersuchungen der inhaltstoffe von Xanthium canadense Mill Green Sustainable Chem 1 123-78
[10]  
Bast RC(2010)Efficiënt isolation of an anti-cancer sesquiterpene lactone from Drug Discov Today 15 668-896